title: Prophylactic OKT3: practical considerations for the prevention of first-dose reactions.
authors: Department of Nephrology, Hôpital Erasme, Université Libre de Bruxelles, Belgium.
authors: J M
authors: JM
authors: Doutrelepont
authors: D
authors: D
authors: Abramowicz
authors: B
authors: B
authors: Borre
authors: A
authors: A
authors: Lemoine
authors: L
authors: L
authors: De Pauw
authors: P
authors: P
authors: Kinnaert
authors: P
authors: P
authors: Vereerstraeten
authors: J L
authors: JL
authors: Vanherweghem
authors: M
authors: M
authors: Goldman
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D006801:Humans; D007432:Intraoperative Period; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011184:Postoperative Period; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D001379:Azathioprine; D008775:Methylprednisolone